Daxor Corporation (NASDAQ: DXR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT DAXOR CORPORATION

Daxor Corporation (NASDAQ: DXR)
Listen to this Section


$10.52
+0.2000 ( +1.94% ) N/A

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Market Data


Open $10.52
Previous Close $10.32
Volume N/A
Market Cap $61.30M
Day Range $10.41 - $10.62
52 Week Range $8.56 - $14.76
Shares Outstanding 5.84M
Change % +1.94%
Net Change ▲ 0.2000
Insider Ownership 0.01%
Exchange NASDAQ
SectorHealthcare
IndustryMedical/Dental Instruments
IPO Year1983
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 53,324.00

Date Type Amount Purchased Purchaser
2024-03-06 Buy 1000.00 Feuer Edward
2023-12-06 Buy 120.00 Michel Robert J
2023-12-01 Buy 180.00 Michel Robert J
2023-12-01 Buy 800.00 Feldschuh Michael Richard
2023-11-27 Buy 500.00 Michel Robert J
2023-11-24 Sale -84.00 Feldschuh Michael Richard
2023-11-13 Buy 401.00 Feldschuh Michael Richard
2023-11-02 Sale -2000.00 Michel Robert J
2023-10-16 Buy 500.00 Michel Robert J
2023-09-20 Sale -25000.00 Estate of Joseph Feldschuh

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 14, 2025
nport-p Other 1 Nov 13, 2025
n-csr/a Other 4 Oct 15, 2025
3 Insider transactions 1 Oct 02, 2025
n-px Other 2 Sep 02, 2025
nt Quarterly Reports 1 Sep 02, 2025
n-csr Other 3 Aug 29, 2025
8-k 8K-related 14 Aug 07, 2025
n-cen/a Other 2 Jul 24, 2025
n-cen/a Other 2 Jul 24, 2025

Latest News